Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey

Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2... Diabetes Ther (2018) 9:1185–1199 https://doi.org/10.1007/s13300-018-0431-3 ORIGINAL RESEARCH Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey . . Hiroki Murayama Kota Imai Masato Odawara Received: March 14, 2018 / Published online: April 25, 2018 The Author(s) 2018 primary endpoints were the proportions of ABSTRACT physicians who considered particular treatment factors and patient characteristics when select- Introduction: The Japanese guidelines for type ing the appropriate treatment for drug-naive 2 diabetes mellitus (T2DM) emphasize individ- T2DM patients. ualization of treatment based on patient need Results: A total of 491 physicians participated and encourage physicians to select an appro- in the survey. Dipeptidyl peptidase-4 inhibitors priate oral antidiabetes drug (OAD). However, (DPP-4is) were the most-preferred first-line limited evidence is available on the factors OADs, followed by metformin, of both special- influencing the selection by physicians (dia- ists (69% vs. 60%) and nonspecialists (73% vs. betes specialists and nonspecialists) of the first- 47%). The most influential factors when a DPP- line OAD to treat drug-naive patients with 4i was selected were found to be glycated T2DM. A survey was designed to explore the hemoglobin (HbA1c), postprandial http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetes Therapy Springer Journals

Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey

Murayama, Hiroki; Imai, Kota; Odawara, Masato
Diabetes Therapy , Volume 9 (3) – Apr 25, 2018
Download PDF
15 pages

Loading next page...
 
/lp/springer_journal/factors-influencing-the-prescribing-preferences-of-physicians-for-drug-SvQGnPf7C0
Publisher
Springer Journals
Copyright
Copyright © 2018 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Diabetes; Cardiology; Endocrinology
ISSN
1869-6953
eISSN
1869-6961
DOI
10.1007/s13300-018-0431-3
Publisher site
See Article on Publisher Site

Abstract

Diabetes Ther (2018) 9:1185–1199 https://doi.org/10.1007/s13300-018-0431-3 ORIGINAL RESEARCH Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey . . Hiroki Murayama Kota Imai Masato Odawara Received: March 14, 2018 / Published online: April 25, 2018 The Author(s) 2018 primary endpoints were the proportions of ABSTRACT physicians who considered particular treatment factors and patient characteristics when select- Introduction: The Japanese guidelines for type ing the appropriate treatment for drug-naive 2 diabetes mellitus (T2DM) emphasize individ- T2DM patients. ualization of treatment based on patient need Results: A total of 491 physicians participated and encourage physicians to select an appro- in the survey. Dipeptidyl peptidase-4 inhibitors priate oral antidiabetes drug (OAD). However, (DPP-4is) were the most-preferred first-line limited evidence is available on the factors OADs, followed by metformin, of both special- influencing the selection by physicians (dia- ists (69% vs. 60%) and nonspecialists (73% vs. betes specialists and nonspecialists) of the first- 47%). The most influential factors when a DPP- line OAD to treat drug-naive patients with 4i was selected were found to be glycated T2DM. A survey was designed to explore the hemoglobin (HbA1c), postprandial

Journal

Diabetes Therapy – Springer Journals

Published: Apr 25, 2018

References

  • Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
    Wild, S; Roglic, G; Green, A; Sicree, R; King, H
  • Lifestyle and glycemic control in Japanese adults receiving diabetes treatment: an analysis of the 2009 Japan Society of Ningen Dock database
    Takahashi, E; Moriyama, K; Yamakado, M
  • Use of oral combination therapy for type 2 diabetes in primary care: meeting individualized patient goals
    Lavernia, F; Adkins, SE; Shubrook, JH
  • Trends in antidiabetic prescription patterns in Japan from 2005 to 2011
    Kohro, T; Yamazaki, T; Sato, H
  • Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and The European Association for the Study of Diabetes
    Inzucchi, SE; Bergenstal, RM; Buse, JB
  • Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: a population-based study
    Rafaniello, C; Arcoraci, V; Ferrajolo, C
  • Long-term trends in antidiabetes drug usage in the U.S.: real-world evidence in patients newly diagnosed with type 2 diabetes
    Montvida, O; Shaw, J; Atherton, JJ; Stringer, F; Paul, SK
  • How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists
    Grant, RW; Wexler, DJ; Watson, AJ
  • Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis
    Filion, KB; Joseph, L; Boivin, JF; Suissa, S; Brophy, JM
  • Use of antidiabetic drugs in the U.S., 2003–2012
    Hampp, C; Borders-Hemphill, V; Moeny, DG; Wysowski, DK
  • Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002–2011 in Japan (JDDM32)
    Oishi, M; Yamazaki, K; Okuguchi, F
  • β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians
    Yabe, D; Seino, Y; Fukushima, M; Seino, S
  • Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis
    Kim, YG; Hahn, S; Oh, TJ; Kwak, SH; Park, KS; Cho, YM
  • New glycemic targets for patients with diabetes from the Japan Diabetes Society
    Araki, E; Haneda, M; Kasuga, M
  • Kobayashi M; Japan Diabetes Clinical Data Management Study Group. Microalbuminuria is common in Japanese type 2 diabetic patients: a nationwide survey from the Japan Diabetes Clinical Data Management Study Group (JDDM 10)
    Yokoyama, H; Kawai, K